LUSHELL HAYES: Open Payments
NPI 1437740842 · ELIZABETH CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 12 payments from 7 companies in 2025. Trend: 2023 $458 · 2024 $1,088 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $71 |
| Novo Nordisk Inc | 3 | $69 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Wegovy, REPATHA, OPSYNVI, UPTRAVI, VERQUVO, ELIQUIS, FARXIGA.
Industry payments across NC — which companies pay providers there.
